Our findings revealed that although the LC3II autophagy marker in patient fibroblasts exhibited significant variation among individuals with PMM2-CDG, its levels were inversely correlated with the clinical CDG severity score and urine sorbitol levels. Here, PMM2 is linked to congenital disorder of glycosylation.